You are here » Home » Companies » Company Overview » Dr Agarwals Eye Hospital Ltd

Dr Agarwals Eye Hospital Ltd.

BSE: 526783 Sector: Health care
NSE: N.A. ISIN Code: INE934C01018
BSE 13:39 | 08 Jul 220.80 -1.70
(-0.76%)
OPEN

240.00

HIGH

240.00

LOW

220.00

NSE 05:30 | 01 Jan Dr Agarwals Eye Hospital Ltd
OPEN 240.00
PREVIOUS CLOSE 222.50
VOLUME 186
52-Week high 341.65
52-Week low 169.20
P/E 7.59
Mkt Cap.(Rs cr) 104
Buy Price 221.85
Buy Qty 10.00
Sell Price 232.75
Sell Qty 1.00
OPEN 240.00
CLOSE 222.50
VOLUME 186
52-Week high 341.65
52-Week low 169.20
P/E 7.59
Mkt Cap.(Rs cr) 104
Buy Price 221.85
Buy Qty 10.00
Sell Price 232.75
Sell Qty 1.00

Dr Agarwals Eye Hospital Ltd. (DRAGARWALSEYE) - Chairman Speech

Company chairman speech

Dear Shareholders

I look back nearly 60 years to when we initially set out to build the first Eye carehospital under our name and then to the journey thereafter in nurturing it into theworld-class Eye care institution it has grown into today. Now the hospital chain in its62nd year of service has a total presence of 22 hospitals across India. Our motivation forthe pursuit of our goals has not wavered a bit through this eventful and challengingjourney.We believe we are best suited to lead the eye care space in the coming years Weoperate a hub and spoke delivery model with well-equipped tertiary hospitals that cater tothe ever increasing need of eye care. Our nation requires quality healthcare players andmedical professionals to further its growth – we are proud to be a crucial part ofthe growth story with our advanced technologies.

We registered a growth of 11% clocking 172.03 INR crores as total income for the yearFY 2018-19. The operating margin for FY 2018-19 stood at 18% compared to an operatingmargin of 17% for the last financial year. The TV ads for the year FY 2018-19 were areasonable success helping us in enhancing our brand recall and we plan to have similarcampaigns this year as well. These branding activities will help us in enhancing our brandawareness. The re-location of our flagship facility at Cathedral Road to TTK Road was aresounding success with no drop in patient volumes. We also managed to relocate two of ourcentres at Velachery and Erode and these fueled our growth for the year. The key takeawayfrom these financial results is that your Company has demonstrated strong growth inrevenues EBIDTA a healthy PAT with overall margin improvements for the year.

I thank my extended family of doctors consultants and staff who have made thisjourney successful. I also thank all our stakeholders especially you our investors forthe faith and trust you have reposed in us and for the continuing support you have shownus over the years.

Prof. Dr. Amar Agarwal
Chairman & Managing Director
Dr. Agarwal's Eye Hospital Limited